dilazep has been researched along with Myocardial Infarction in 8 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present investigation was undertaken to evaluate the effects of Dilazep, a new antiplatelet and coronary dilating drug, on the exercise tolerance of patients who had suffered previous myocardial infarction and were participating in a cardiac rehabilitation programme." | 9.05 | Efficacy of Dilazep in patients with previous myocardial infarction participating in a cardiac rehabilitation programme. ( Cefis, M; Cerri, B; Fonte, S; Grasso, S; Ugolini, C, 1983) |
| "To assess whether dilazep reduces myocardial necrosis we assigned 72 rats that survived coronary artery occlusion to 3 groups." | 7.66 | Dilazep-induced reduction of ischemic necrosis in rats with coronary artery occlusion. ( Ambrosio, G; Brevetti, G; Cataffo, A; Chiariello, M; Condorelli, M; Genovese, A, 1983) |
| "The present investigation was undertaken to evaluate the effects of Dilazep, a new antiplatelet and coronary dilating drug, on the exercise tolerance of patients who had suffered previous myocardial infarction and were participating in a cardiac rehabilitation programme." | 5.05 | Efficacy of Dilazep in patients with previous myocardial infarction participating in a cardiac rehabilitation programme. ( Cefis, M; Cerri, B; Fonte, S; Grasso, S; Ugolini, C, 1983) |
| "To assess whether dilazep reduces myocardial necrosis we assigned 72 rats that survived coronary artery occlusion to 3 groups." | 3.66 | Dilazep-induced reduction of ischemic necrosis in rats with coronary artery occlusion. ( Ambrosio, G; Brevetti, G; Cataffo, A; Chiariello, M; Condorelli, M; Genovese, A, 1983) |
| "Myocardial infarction was induced in rabbits by 30-min coronary occlusion and 72-h reperfusion." | 1.29 | Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning. ( Iimura, O; Itoya, M; Miura, T; Sakamoto, J; Urabe, K, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toyooka, T | 1 |
| Kamishiro, T | 1 |
| Fumino, H | 1 |
| Masaki, T | 1 |
| Hosoda, S | 1 |
| Grasso, S | 1 |
| Cefis, M | 1 |
| Fonte, S | 1 |
| Ugolini, C | 1 |
| Cerri, B | 1 |
| Chiariello, M | 1 |
| Brevetti, G | 1 |
| Genovese, A | 1 |
| Cataffo, A | 1 |
| Ambrosio, G | 1 |
| Condorelli, M | 1 |
| Sone, T | 1 |
| Kobayashi, T | 1 |
| Mizutani, K | 1 |
| Yamamoto, M | 1 |
| Watanabe, T | 1 |
| Parenti, B | 1 |
| Selvaggi, R | 1 |
| Itoya, M | 1 |
| Miura, T | 1 |
| Sakamoto, J | 1 |
| Urabe, K | 1 |
| Iimura, O | 1 |
| Gupta, JB | 1 |
| Seth, SD | 1 |
| Singh, U | 1 |
| Vyas, DS | 1 |
| Koshu, M | 1 |
| Sugimoto, T | 1 |
| Terada, Y | 1 |
| Uraoka, T | 1 |
1 trial available for dilazep and Myocardial Infarction
| Article | Year |
|---|---|
Efficacy of Dilazep in patients with previous myocardial infarction participating in a cardiac rehabilitation programme.
Topics: Adult; Azepines; Dilazep; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Ph | 1983 |
7 other studies available for dilazep and Myocardial Infarction
| Article | Year |
|---|---|
Rabbit hearts for the critical evaluation of drugs to reduce the size of experimentally produced acute myocardial infarction.
Topics: Animals; Calcium Channel Blockers; Dilazep; Male; Myocardial Infarction; Myocardium; Propranolol; Ra | 1984 |
Dilazep-induced reduction of ischemic necrosis in rats with coronary artery occlusion.
Topics: Animals; Azepines; Coronary Circulation; Coronary Disease; Dilazep; Male; Myocardial Infarction; Nec | 1983 |
A study on the noninvasive evaluation of coronary vasodilating drugs with Thallium-201 myocardial imagings.
Topics: Adult; Angina Pectoris; Cardiac Output; Coronary Circulation; Coronary Disease; Coronary Vessels; Di | 1981 |
[Polygraphic and electrocardiographic study of a new coronary therapeutic agent: dilazep].
Topics: Adult; Aged; Azepines; Coronary Disease; Dilazep; Electrocardiography; Exercise Test; Female; Heart | 1980 |
Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning.
Topics: Animals; Blood Pressure; Dilazep; Disease Models, Animal; Epoprostenol; Heart Rate; Injections, Intr | 1994 |
Effects of dilazep in evolving myocardial infarction in dogs: a biochemical study.
Topics: Adenosine Triphosphate; Animals; Azepines; Cyclic AMP; Dilazep; Disease Models, Animal; Dogs; Fatty | 1989 |
Effect of dilazep on hemoglobin-oxygen affinity in patients with ischemic heart disease.
Topics: 2,3-Diphosphoglycerate; Administration, Oral; Adult; Aged; Aldosterone; Angina Pectoris; Azepines; C | 1985 |